150 related articles for article (PubMed ID: 32623923)
1. ACE (Angiotensin-Converting Enzyme) Inhibitors/Angiotensin Receptor Blockers Are Associated With Lower Colorectal Cancer Risk: A Territory-Wide Study With Propensity Score Analysis.
Cheung KS; Chan EW; Seto WK; Wong ICK; Leung WK
Hypertension; 2020 Sep; 76(3):968-975. PubMed ID: 32623923
[TBL] [Abstract][Full Text] [Related]
2. Nonsteroidal anti-inflammatory drugs but not aspirin are associated with a lower risk of post-colonoscopy colorectal cancer.
Cheung KS; Chen L; Chan EW; Seto WK; Wong ICK; Leung WK
Aliment Pharmacol Ther; 2020 May; 51(9):899-908. PubMed ID: 32201976
[TBL] [Abstract][Full Text] [Related]
3. Use of β-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and risk of breast cancer recurrence: a Danish nationwide prospective cohort study.
Sørensen GV; Ganz PA; Cole SW; Pedersen LA; Sørensen HT; Cronin-Fenton DP; Garne JP; Christiansen PM; Lash TL; Ahern TP
J Clin Oncol; 2013 Jun; 31(18):2265-72. PubMed ID: 23650417
[TBL] [Abstract][Full Text] [Related]
4. Renin-angiotensin system inhibitors, angiotensin I-converting enzyme gene insertion/deletion polymorphism, and cancer: the Rotterdam Study.
van der Knaap R; Siemes C; Coebergh JW; van Duijn CM; Hofman A; Stricker BH
Cancer; 2008 Feb; 112(4):748-57. PubMed ID: 18181094
[TBL] [Abstract][Full Text] [Related]
5. Prospective Cohort Study of Renin-Angiotensin System Blocker Usage after Hospitalized Acute Kidney Injury.
Brar S; Liu KD; Go AS; Hsu RK; Chinchilli VM; Coca SG; Garg AX; Himmelfarb J; Ikizler TA; Kaufman J; Kimmel PL; Parikh CR; Siew ED; Ware LB; Zeng H; Hsu CY; ;
Clin J Am Soc Nephrol; 2020 Dec; 16(1):26-36. PubMed ID: 33272913
[TBL] [Abstract][Full Text] [Related]
6. Statins reduce the progression of non-advanced adenomas to colorectal cancer: a postcolonoscopy study in 187 897 patients.
Cheung KS; Chen L; Chan EW; Seto WK; Wong ICK; Leung WK
Gut; 2019 Nov; 68(11):1979-1985. PubMed ID: 30808646
[TBL] [Abstract][Full Text] [Related]
7. Renin-Angiotensin System Blockers and Adverse Outcomes of Influenza and Pneumonia: A Danish Cohort Study.
Christiansen CF; Heide-Jørgensen U; Rasmussen TB; Bodilsen J; Søgaard OS; Maeng M; Vistisen ST; Schmidt M; Pottegård A; Lund LC; Reilev M; Hallas J; Johansen NB; Brun NC; Sørensen HT; Thomsen RW
J Am Heart Assoc; 2020 Oct; 9(19):e017297. PubMed ID: 32998607
[TBL] [Abstract][Full Text] [Related]
8. Association Between Renin-Angiotensin System Blockade Discontinuation and All-Cause Mortality Among Persons With Low Estimated Glomerular Filtration Rate.
Qiao Y; Shin JI; Chen TK; Inker LA; Coresh J; Alexander GC; Jackson JW; Chang AR; Grams ME
JAMA Intern Med; 2020 May; 180(5):718-726. PubMed ID: 32150237
[TBL] [Abstract][Full Text] [Related]
9. Risk of Osteoporotic Fractures With Angiotensin II Receptor Blockers Versus Angiotensin-Converting Enzyme Inhibitors in Hypertensive Community-Dwelling Elderly.
Butt DA; Mamdani M; Gomes T; Lix L; Lu H; Tu K;
J Bone Miner Res; 2014 Nov; 29(11):2483-8. PubMed ID: 24806397
[TBL] [Abstract][Full Text] [Related]
10. Effect of Renin-Angiotensin-Aldosterone System Blockade on Long-Term Outcomes in Postacute Kidney Injury Patients With Hypertension.
Yang CY; Liu JS; Tseng WC; Tsai MT; Lin MH; Kao ZK; Lin YP; Hsu CC; Tarng DC
Crit Care Med; 2020 Dec; 48(12):e1185-e1193. PubMed ID: 32932351
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk.
Makar GA; Holmes JH; Yang YX
J Natl Cancer Inst; 2014 Feb; 106(2):djt374. PubMed ID: 24431411
[TBL] [Abstract][Full Text] [Related]
12. Renin-Angiotensin-Aldosterone System-based Antihypertensive Agents and the Risk of Colorectal Cancer Among Medicare Beneficiaries.
Htoo PT; Stürmer T; Jonsson-Funk M; Pate V; Simpson RJ; Lund JL
Epidemiology; 2019 Nov; 30(6):867-875. PubMed ID: 31348009
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin receptor blockers and risk of cancer: cohort study among people receiving antihypertensive drugs in UK General Practice Research Database.
Bhaskaran K; Douglas I; Evans S; van Staa T; Smeeth L
BMJ; 2012 Apr; 344():e2697. PubMed ID: 22531797
[TBL] [Abstract][Full Text] [Related]
14. Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension: A Single-Center Retrospective Study.
Yang G; Tan Z; Zhou L; Yang M; Peng L; Liu J; Cai J; Yang R; Han J; Huang Y; He S
Hypertension; 2020 Jul; 76(1):51-58. PubMed ID: 32348166
[TBL] [Abstract][Full Text] [Related]
15. Effect of Renin-Angiotensin-Aldosterone System Inhibitors on Short-Term Mortality After Sepsis: A Population-Based Cohort Study.
Hsu WT; Galm BP; Schrank G; Hsu TC; Lee SH; Park JY; Lee CC
Hypertension; 2020 Feb; 75(2):483-491. PubMed ID: 31838905
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin receptor blocker in patients with ST segment elevation myocardial infarction with preserved left ventricular systolic function: prospective cohort study.
Yang JH; Hahn JY; Song YB; Choi SH; Choi JH; Lee SH; Jeong MH; Choi DJ; Park JS; Park HS; Gwon HC
BMJ; 2014 Nov; 349():g6650. PubMed ID: 25398372
[TBL] [Abstract][Full Text] [Related]
17. ARB users exhibit a lower fracture incidence than ACE inhibitor users among older hypertensive men.
Kwok T; Leung J; Barrett-Connor E;
Age Ageing; 2017 Jan; 46(1):57-64. PubMed ID: 28181652
[TBL] [Abstract][Full Text] [Related]
18. Does Angiotensin-Converting Enzyme Inhibitor and β-Blocker Use Reduce the Risk of Primary Liver Cancer? A Case-Control Study Using the U.K. Clinical Practice Research Datalink.
Hagberg KW; Sahasrabuddhe VV; McGlynn KA; Jick SS
Pharmacotherapy; 2016 Feb; 36(2):187-95. PubMed ID: 26846893
[TBL] [Abstract][Full Text] [Related]
19. Renin-angiotensin system blocker use and the risk of acute kidney injury after colorectal cancer surgery: a population-based cohort study.
Slagelse C; Gammelager H; Iversen LH; Liu KD; Sørensen HTT; Christiansen CF
BMJ Open; 2019 Nov; 9(11):e032964. PubMed ID: 31753901
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive Drugs and COVID-19 Risk: A Cohort Study of 2 Million Hypertensive Patients.
Semenzato L; Botton J; Drouin J; Baricault B; Vabre C; Cuenot F; Penso L; Herlemont P; Sbidian E; Weill A; Dray-Spira R; Zureik M
Hypertension; 2021 Mar; 77(3):833-842. PubMed ID: 33423528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
